Chronic pain patients enrolled in a statewide medical marijuana program are more likely to reduce their use of prescription drugs than are those patients who don’t use cannabis, according to data published online ahead of print in the Journal of Post-Acute and Long-Term Care Medicine.
In a quick deal between President Trump and Congress, a three-month budget continuing resolution will be in effect until December 8, 2017, maintaining current spending levels. While this seems mundane (it is), it is important for marijuana policy because it guarantees a temporary extension of the Rohrabacher-Blumenauer protections for lawful medical marijuana programs from Attorney General Jeff Sessions.
Fewer young people today identify as current users of cannabis as compared to 2002, according to national survey data released today by the US Department of Health and Human Services, Substance Abuse and Mental Health Services administration.
Late Wednesday night, the House Rules Committee led by prohibitionist Representative Pete Sessions (R-TX) blocked multiple amendments related to marijuana from receiving consideration by the full House, thus ending their consideration and silencing the ability for the lower chamber to offer protections from Attorney General Jeff Sessions when it comes to cannabis.